February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant

February 19, 2025

Oral Disease Spending Tops Ischemic Heart Disease

Spending on oral diseases ($93 billion) falls between musculoskeletal diseases ($108.6 billion) and ischemic heart disease ($80.7 billion). 

Conexiant

February 14, 2025

Additional Ophthalmic Complications Associated with GLP-1 Use Identified in Case Series

AAO provides guidance in response.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 12, 2025

FDA Approves Mirdametinib for NF1-Associated Plexiform Neurofibromas

Data from the phase III ReNeu trial showed the kinase inhibitor led to an overall response rate of 41% in adult patients and 52% in pediatric patients.

Conexiant

February 03, 2025

Rural Clinics Expand, Medicaid Coverage Stalls

Clemson University is addressing health care needs in rural South Carolina, where uninsured patients, linguistic preferences, and limited Medicaid expansion pose challenges. Learn about their initiatives to improve health care access.

KFF Health News

February 03, 2025

PICU Delay Linked to Dialysis Dependency

Researchers analyze kidney replacement therapies in pediatric crush syndrome. Their findings emphasized dialysis dependency and pediatric intensive care unit outcomes post-earthquake.

Conexiant

January 29, 2025

Fracture Infection Treatment: Oral vs Intravenous Data

A trial compared oral versus intravenous antibiotics for fracture-related infections.

Conexiant

January 29, 2025

Medication Burden and Injurious Falls Among Patients With COPD

Agents such as benzodiazepines, sedative-hypnotics, antihypertensives, and other psychoactive drugs—often used to treat comorbidities in patients with COPD—may be contributing to an increased risk of falls among this population near the end of life.

Conexiant